Skip to content

Evaluation of postoperative pain and haemodynamic effects of Intraperitoneal instillation of Buprenorphine with Bupivacaine versus Bilateral transversus abdominis plane block using Buprenorphine with Bupivacaine for Laparoscopic Cholecystectomy: A Comparative study

Evaluation of postoperative analgesic effects of Intraperitoneal instillation of Buprenorphine with Bupivacaine versus Bilateral transversus abdominis plane block using Buprenorphine with Bupivacaine for Laparoscopic Cholecystectomy: A Comparative study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060812
Enrollment
60
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: intraperitoneal instillation: Intraperitoneal instillation will 24ml of 0.25% bupivacaine with 300mcg buprenorphine in the gall bladder fossa , upper surface of liver and hepatorenal

Sponsors

BGS Global Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Physical status 1 and 2 Age group 18 to 60 years Elective laparoscopic cholecystectomy posted patients

Exclusion criteria

Exclusion criteria: ASA Physical status 3 and 4 Patients with history of anaphylaxis to local anaesthetics and/or opioids or drugs to be used Patients with history of drug abuse and psychiatric disease Morbidly obese patients

Design outcomes

Primary

MeasureTime frame
Post operative painTimepoint: 0min, 30min, 1hour, 2hour, 4hour, 8hour, 12hour, 16hour, 20hour and 24hour post operatively

Secondary

MeasureTime frame
Total rescue analgesic consumption in first 24 hrs Hemodynamic parameters and complications in next 24 hoursTimepoint: 24 hours after surgery

Countries

India

Contacts

Public ContactDr H Sumana

BGS Global Institute Of Medical Sciences

geetp11@gmail.com9739945846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026